Global Market Study on Antibody Testing: Rise in Prevalence of Chronic Diseases to Heighten Demand

Global Market Study on Antibody Testing: Rise in Prevalence of Chronic Diseases to Heighten Demand

  • Persistence Market Research
  • September 2020
  • Therapeutic Area
  • 235 pages

Table of Content

 

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Market Evolution
1.5. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Key Market Trends
3.1. Demand Side Trends
3.2. Supply Side Trends

4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global Healthcare Outlook 
4.1.2. Global Biotech and Biopharma Industry Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Prevalence of Various Diseases
4.2.2. Historic Growth of Key Manufacturers
4.2.3. Adoption of Antibody Testing Kits
4.2.4. Product in Pipeline
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
4.4. COVID-19 Analysis

5. Key Success Factors
5.1. Diseases Epidemiology
5.2. Regulatory Landscape
5.3. Pipeline Assessment
5.4. Key Strategies by Manufacturer 

6. Global Antibody Testing Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis

7. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Product  
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product, 2015–2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2020-2030
7.3.1. Kits
7.3.1.1. Serological Test Kits
7.3.1.1.1. Serological Assay Test Kits
7.3.1.1.2. Serological Rapid Assay Kits
7.3.1.2. Immunoglobulin Kits
7.3.1.2.1. Immunoglobulin Assay Test Kits
7.3.1.2.2. Immunoglobulin Rapid Assay Kits
7.3.1.3. Lateral Flow Assay Kits
7.3.1.3.1. Lateral Flow Assay Test Kits
7.3.1.3.2. Lateral Flow Rapid Assay Kits
7.3.2. Chemical and Reagents
7.3.3. Consumables 
7.4. Market Attractiveness Analysis By Product Type

8. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Indication 
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015–2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020-2030
8.3.1. Pregnancy  
8.3.2. Cardiovascular Diseases
8.3.3. Autoimmune Diseases
8.3.4. Infectious Diseases
8.3.5. Oncology
8.3.6. Endocrine Diseases
8.3.7. Diabetes 
8.3.8. Others
8.4. Market Attractiveness Analysis By Indication

9. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
9.3.1. Hospitals
9.3.2. Academic and Research Institutes
9.3.3. Diagnostic Laboratories
9.3.4. Biopharmaceutical Companies
9.3.5. Homecare Settings 
9.4. Market Attractiveness Analysis By End User

10. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
11.3.1.  By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Product
11.3.3. By Indication
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis

12. Latin America Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
12.3.1.  By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product
12.3.3. By Indication
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis

13. Europe Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
13.3.1.  By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. Rest of Europe
13.3.2. By Product
13.3.3. By Indication
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis

14. East Asia Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
14.3.1.  By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.1.4. 
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis

15. South Asia Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
15.3.1.  By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia 
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis

16. Oceania Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
16.3.1.  By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
17.3.1.  By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis

18. Key and Emerging Countries Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. U.S. Antibody Testing Market Analysis
18.2.1. By Product  
18.2.2. By Indication
18.2.3. By End User
18.3. Canada Antibody Testing Market Analysis
18.3.1. By Product  
18.3.2. By Indication
18.3.3. By End User
18.4. Mexico Antibody Testing Market Analysis
18.4.1. By Product  
18.4.2. By Indication
18.4.3. By End User
18.5. Argentina Antibody Testing Market Analysis
18.5.1. By Product  
18.5.2. By Indication
18.5.3. By End User
18.6. Brazil Antibody Testing Market Analysis
18.6.1. By Product  
18.6.2. By Indication
18.6.3. By End User
18.7. U.K. Antibody Testing Market Analysis
18.7.1. By Product  
18.7.2. By Indication
18.7.3. By End User
18.8. Germany Antibody Testing Market Analysis
18.8.1. By Product  
18.8.2. By Indication
18.8.3. By End User
18.9. France Antibody Testing Market Analysis
18.9.1. By Product  
18.9.2. By Indication
18.9.3. By End User
18.10. Italy Antibody Testing Market Analysis
18.10.1. By Product  
18.10.2. By Indication
18.10.3. By End User
18.11. Spain Antibody Testing Market Analysis
18.11.1. By Product  
18.11.2. By Indication
18.11.3. By End User
18.12. Russia Antibody Testing Market Analysis
18.12.1. By Product  
18.12.2. By Indication
18.12.3. By End User
18.13. China Antibody Testing Market Analysis
18.13.1. By Product  
18.13.2. By Indication
18.13.3. By End User
18.14. Japan Antibody Testing Market Analysis
18.14.1. By Product  
18.14.2. By Indication
18.14.3. By End User
18.15. South Korea Antibody Testing Market Analysis
18.15.1. By Product  
18.15.2. By Indication
18.15.3. By End User
18.16. India Antibody Testing Market Analysis
18.16.1. By Product  
18.16.2. By Indication
18.16.3. By End User
18.17. Indonesia Antibody Testing Market Analysis
18.17.1. By Product  
18.17.2. By Indication
18.17.3. By End User
18.18. Malaysia Antibody Testing Market Analysis
18.18.1. By Product  
18.18.2. By Indication
18.18.3. By End User
18.19. Australia Antibody Testing Market Analysis
18.19.1. By Product  
18.19.2. By Indication
18.19.3. By End User
18.20. New Zealand Antibody Testing Market Analysis
18.20.1. By Product  
18.20.2. By Indication
18.20.3. By End User
18.21. GCC Countries Antibody Testing Market Analysis
18.21.1. By Product  
18.21.2. By Indication
18.21.3. By End User
18.22. Turkey Antibody Testing Market Analysis
18.22.1. By Product  
18.22.2. By Indication
18.22.3. By End User
18.23. South Africa Antibody Testing Market Analysis
18.23.1. By Product  
18.23.2. By Indication
18.23.3. By End User

19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies 
19.2. Market Share Analysis of Top Players

20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Deep Dive 
20.2.1. Thermo Fisher Scientific.
20.2.1.1. Company Overview
20.2.1.2. Product Overview
20.2.1.3. Profitability by Market Segments (Service/Channel/Region)
20.2.1.4. Sales Footprint
20.2.1.5. Strategy Overview
20.2.1.5.1. Marketing Strategy
20.2.1.5.2. Service Strategy
20.2.1.5.3. Channel Strategy
20.2.2. Abbott Laboratories
20.2.2.1. Company Overview
20.2.2.2. Product Overview
20.2.2.3. Profitability by Market Segments (Service/Channel/Region)
20.2.2.4. Sales Footprint
20.2.2.5. Strategy Overview
20.2.2.5.1. Marketing Strategy
20.2.2.5.2. Service Strategy
20.2.2.5.3. Channel Strategy
20.2.3. Bio-Rad Laboratories, Inc.
20.2.3.1. Company Overview
20.2.3.2. Product Overview
20.2.3.3. Profitability by Market Segments (Service/Channel/Region)
20.2.3.4. Sales Footprint
20.2.3.5. Strategy Overview
20.2.3.5.1. Marketing Strategy
20.2.3.5.2. Service Strategy
20.2.3.5.3. Channel Strategy
20.2.4. Beckton, Dickinson and Company
20.2.4.1. Company Overview
20.2.4.2. Product Overview
20.2.4.3. Profitability by Market Segments (Service/Channel/Region)
20.2.4.4. Sales Footprint
20.2.4.5. Strategy Overview
20.2.4.5.1. Marketing Strategy
20.2.4.5.2. Service Strategy
20.2.4.5.3. Channel Strategy
20.2.5. F. Hoffmann-La Roche
20.2.5.1. Company Overview
20.2.5.2. Product Overview
20.2.5.3. Profitability by Market Segments (Service/Channel/Region)
20.2.5.4. Sales Footprint
20.2.5.5. Strategy Overview
20.2.5.5.1. Marketing Strategy
20.2.5.5.2. Service Strategy
20.2.5.5.3. Channel Strategy
20.2.6. Agilent Technologies
20.2.6.1. Company Overview
20.2.6.2. Product Overview
20.2.6.3. Profitability by Market Segments (Service/Channel/Region)
20.2.6.4. Sales Footprint
20.2.6.5. Strategy Overview
20.2.6.5.1. Marketing Strategy
20.2.6.5.2. Service Strategy
20.2.6.5.3. Channel Strategy
20.2.7. DiaSorin
20.2.7.1. Company Overview
20.2.7.2. Product Overview
20.2.7.3. Profitability by Market Segments (Service/Channel/Region)
20.2.7.4. Sales Footprint
20.2.7.5. Strategy Overview
20.2.7.5.1. Marketing Strategy
20.2.7.5.2. Service Strategy
20.2.7.5.3. Channel Strategy
20.2.8. Zeus Scientific
20.2.8.1. Company Overview
20.2.8.2. Product Overview
20.2.8.3. Profitability by Market Segments (Service/Channel/Region)
20.2.8.4. Sales Footprint
20.2.8.5. Strategy Overview
20.2.8.5.1. Marketing Strategy
20.2.8.5.2. Service Strategy
20.2.8.5.3. Channel Strategy
20.2.9. Abcam
20.2.9.1. Company Overview
20.2.9.2. Product Overview
20.2.9.3. Profitability by Market Segments (Service/Channel/Region)
20.2.9.4. Sales Footprint
20.2.9.5. Strategy Overview
20.2.9.5.1. Marketing Strategy
20.2.9.5.2. Service Strategy
20.2.9.5.3. Channel Strategy
20.2.10. Trinity Biotech
20.2.10.1. Company Overview
20.2.10.2. Product Overview
20.2.10.3. Profitability by Market Segments (Service/Channel/Region)
20.2.10.4. Sales Footprint
20.2.10.5. Strategy Overview
20.2.10.5.1. Marketing Strategy
20.2.10.5.2. Service Strategy
20.2.10.5.3. Channel Strategy
20.2.11. Werfen (Biokit)
20.2.11.1. Company Overview
20.2.11.2. Product Overview
20.2.11.3. Profitability by Market Segments (Service/Channel/Region)
20.2.11.4. Sales Footprint
20.2.11.5. Strategy Overview
20.2.11.5.1. Marketing Strategy
20.2.11.5.2. Service Strategy
20.2.11.5.3. Channel Strategy
20.2.12. Promega
20.2.12.1. Company Overview
20.2.12.2. Product Overview
20.2.12.3. Profitability by Market Segments (Service/Channel/Region)
20.2.12.4. Sales Footprint
20.2.12.5. Strategy Overview
20.2.12.5.1. Marketing Strategy
20.2.12.5.2. Service Strategy
20.2.12.5.3. Channel Strategy
20.2.13. BioLegend
20.2.13.1. Company Overview
20.2.13.2. Product Overview
20.2.13.3. Profitability by Market Segments (Service/Channel/Region)
20.2.13.4. Sales Footprint
20.2.13.5. Strategy Overview
20.2.13.5.1. Marketing Strategy
20.2.13.5.2. Service Strategy
20.2.13.5.3. Channel Strategy
20.2.14. Meridian Bioscience
20.2.14.1. Company Overview
20.2.14.2. Product Overview
20.2.14.3. Profitability by Market Segments (Service/Channel/Region)
20.2.14.4. Sales Footprint
20.2.14.5. Strategy Overview
20.2.14.5.1. Marketing Strategy
20.2.14.5.2. Service Strategy
20.2.14.5.3. Channel Strategy
20.2.15. Bio-Techne (R&D Systems)
20.2.15.1. Company Overview
20.2.15.2. Product Overview
20.2.15.3. Profitability by Market Segments (Service/Channel/Region)
20.2.15.4. Sales Footprint
20.2.15.5. Strategy Overview
20.2.15.5.1. Marketing Strategy
20.2.15.5.2. Service Strategy
20.2.15.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

 

List of Tables

Table 01: COVID-19 Region-wise Analysis 
Table 02: Pipeline Assessment of Antibody Tests
Table 03: Global Antibody Testing Market Value (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, by Product Type
Table 04: Global Antibody Testing Market (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Indication
Table 05: Global Antibody Testing Market (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by End User
Table 06: Global Antibody Testing Market (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Region
Table 07: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 08: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 09: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 10: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 11: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 12: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 13: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 14: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 15: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 16: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 17: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 18: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 19: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 20: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 21: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 22: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 23: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 24: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 25: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 26: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 27: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 28: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 29: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 30: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
Table 31: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
Table 32: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
Table 33: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
Table 34: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users

 

List of Figures

Figure 01: Antibody Testing Market Share by, Product (2020)
Figure 02: Antibody Testing Market Share by, Indication (2020)
Figure 03: Antibody Testing Market Share by, End User (2020)
Figure 04: Antibody Testing Market Share by, Region (2020)
Figure 05: Historical Market Value (US$ Mn) Analysis, 2015-2019
Figure 06: Y-o-Y Growth Trend Analysis
Figure 07: Absolute $ Opportunity Analysis
Figure 08: Global Antibody Testing Market Share Analysis (%) by Product Type, 2020& 2030
Figure 09: Global Antibody Testing Market Y-o-Y Growth (%) by Product Type, 2020–2030
Figure 10: Global Antibody Testing Market Attractiveness Analysis by Product Type, 2020–2030
Figure 11: Global Antibody Testing Market Share Analysis (%) by Indication, 2020 & 2030
Figure 12: Global Antibody Testing Market Y-o-Y Growth (%) by Indication, 2020–2030
Figure 13: Global Antibody Testing Market Attractiveness Analysis by End User, 2020–2030
Figure 14: Global Antibody Testing Market Share Analysis (%) by End User, 2020 & 2030
Figure 15: Global Antibody Testing Market Y-o-Y Growth (%) by End User, 2020–2030
Figure 16: Global Antibody Testing Market Attractiveness Analysis by End User, 2020–2030
Figure 17: Global Antibody Testing Market Share Analysis (%) by Region, 2020 & 2030
Figure 18: Global Antibody Testing Market Y-o-Y Growth (%) by Region, 2020–2030
Figure 19: Global Antibody Testing Market Attractiveness Analysis by Region, 2020–2030
Figure 20: North America Antibody Testing Market (US$ Mn) Analysis, 2015–2019
Figure 21: North America Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019–2030
Figure 22: North America Antibody Testing Market Attractiveness Analysis by Product, 2020–2030
Figure 23: North America Antibody Testing Market Attractiveness Analysis by Indication, 2020–2030
Figure 24: North America Antibody Testing Market Attractiveness Analysis by End User, 2020–2030
Figure 25: North America Antibody Testing Market Attractiveness Analysis by Country, 2020–2030
Figure 26: Latin America Antibody Testing Market (US$ Mn) Analysis, 2015–2019
Figure 27: Latin America Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019–2030
Figure 28: Latin America Antibody Testing Market Attractiveness Analysis by Product, 2020–2030
Figure 29: Latin America Antibody Testing Market Attractiveness Analysis by Indication, 2020–2030
Figure 30: Latin America Antibody Testing Market Attractiveness Analysis by End User, 2020–2030
Figure 31: Latin America Antibody Testing Market Attractiveness Analysis by Country, 2020–2030
Figure 32: Europe Antibody Testing Market (US$ Mn) Analysis, 2015–2019
Figure 33: Europe Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019–2030
Figure 34: Europe Antibody Testing Market Attractiveness Analysis by Product, 2020–2030
Figure 35: Europe Antibody Testing Market Attractiveness Analysis by Indication, 2020–2030
Figure 36: Europe Antibody Testing Market Attractiveness Analysis by End User, 2020–2030
Figure 37: Europe Antibody Testing Market Attractiveness Analysis by Country, 2020–2030
Figure 38: East Asia Antibody Testing Market (US$ Mn) Analysis, 2015–2019
Figure 39: East Asia Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019–2030
Figure 40: East Asia Antibody Testing Market Attractiveness Analysis by Product, 2020–2030
Figure 41: East Asia Antibody Testing Market Attractiveness Analysis by Indication, 2020–2030
Figure 42: East Asia Antibody Testing Market Attractiveness Analysis by End User, 2020–2030
Figure 43: East Asia Antibody Testing Market Attractiveness Analysis by Country, 2020–2030
Figure 44: South Asia Antibody Testing Market (US$ Mn) Analysis, 2015–2019
Figure 45: South Asia Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019–2030
Figure 46: South Asia Antibody Testing Market Attractiveness Analysis by Product, 2020–2030
Figure 47: South Asia Antibody Testing Market Attractiveness Analysis by Indication, 2020–2030
Figure 48: South Asia Antibody Testing Market Attractiveness Analysis by End User, 2020–2030
Figure 49: South Asia Antibody Testing Market Attractiveness Analysis by Country, 2020–2030
Figure 50: Oceania Antibody Testing Market(US$ Mn) Analysis, 2015–2019
Figure 51: Oceania Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019–2030
Figure 52: Oceania Antibody Testing Market Attractiveness Analysis by Product, 2020–2030
Figure 53: Oceania Antibody Testing Market Attractiveness Analysis by Indication, 2020–2030
Figure 54: Oceania Antibody Testing Market Attractiveness Analysis by End User, 2020–2030
Figure 55: Oceania Antibody Testing Market Attractiveness Analysis by Country, 2020–2030
Figure 56: MEA Antibody Testing Market (US$ Mn) Analysis, 2015–2019
Figure 57: MEA Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019–2030
Figure 58: MEA Antibody Testing Market Attractiveness Analysis by Product, 2020–2030
Figure 59: MEA Antibody Testing Market Attractiveness Analysis by Indication, 2020–2030
Figure 60: MEA Antibody Testing Market Attractiveness Analysis by End User, 2020–2030
Figure 61: MEA Antibody Testing Market Attractiveness Analysis by Country, 2020–2030
Figure 62: U.S. Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 63: U.S. Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 64: U.S. Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 65: Canada Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 66: Canada Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 67: Canada Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 68: Brazil Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 69: Brazil Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 70: Brazil Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 71: Mexico Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 72: Mexico Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 73: Mexico Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 74: Argentina Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 75: Argentina Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 76: Argentina Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 77: Rest of Latin America Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 78: Rest of Latin America Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 79: Rest of Latin America Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 80: U.K. Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 81: U.K.  Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 82: U.K. Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 83: Germany Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 84: Germany Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 85: Germany Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 86: France Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 87: France  Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 88: France Antibody Testing Market Share Analysis %), by End User, 2019
Figure 89: Italy Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 90: Italy Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 91: Italy Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 92: Spain Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 93: Spain Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 94: Spain Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 95: Russia Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 96: Russia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 97: Russia Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 98: Rest of Europe Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 99: Rest of Europe   Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 100: Rest of Europe Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 101: China Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 102: China Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 103: China Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 104: Japan Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 105: Japan Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 106: Japan Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 107: South Korea Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 108: South Korea Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 109: South Korea Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 110: India Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 111: India Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 112: India Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 113: Malaysia Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 114: Malaysia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 115: Malaysia Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 116: Indonesia Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 117: Indonesia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 118: Indonesia Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 119: Rest of South Asia Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 120: Rest of South Asia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 121: Rest of South Asia Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 122: Australia Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 123: Australia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 124: Australia Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 125: New Zealand Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 126: New Zealand Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 127: New Zealand Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 128: GCC Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 129: GCC Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 130: GCC Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 131: Turkey Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 132: Turkey Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 133: Turkey Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 134: South Africa Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 135: South Africa Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 136: South Africa Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 137: North Africa Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 138: North Africa Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 139: North Africa Antibody Testing Market Share Analysis (%), by End User, 2019
Figure 140: Rest of MEA Antibody Testing Market Share Analysis (%), by Product, 2019
Figure 141: Rest of MEA Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
Figure 142: Rest of MEA Antibody Testing Market Share Analysis (%), by End User, 2019

 

Have query on this report?

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074